161 related articles for article (PubMed ID: 8996546)
21. [Features of filamentous cytoskeletons in acquired multidrug-resistance of HL-60 human leukemia cell line].
Kawamura K
Hokkaido Igaku Zasshi; 1994 Mar; 69(2):354-71. PubMed ID: 7908888
[TBL] [Abstract][Full Text] [Related]
22. Increased 14-3-3ζ expression in the multidrug-resistant leukemia cell line HL-60/VCR as compared to the parental line mediates cell growth and apoptosis in part through modification of gene expression.
Liang R; Chen XQ; Bai QX; Wang Z; Zhang T; Yang L; Dong BX; Gao GX; Gu HT; Zhu HF
Acta Haematol; 2014; 132(2):177-86. PubMed ID: 24603438
[TBL] [Abstract][Full Text] [Related]
23. Reduced cellular transport and activation of fluoropyrimidine nucleosides and resistance in human lymphocytic cell lines selected for arabinosylcytosine resistance.
Agarwal RP; Han T; Fernandez M
Biochem Pharmacol; 2001 Jan; 61(1):39-47. PubMed ID: 11137707
[TBL] [Abstract][Full Text] [Related]
24. Cross-resistance to cytosine arabinoside in a multidrug-resistant human promyelocytic cell line selected for resistance to doxorubicin: implications for combination chemotherapy.
Månsson E; Paul A; Löfgren C; Ullberg K; Paul C; Eriksson S; Albertioni F
Br J Haematol; 2001 Sep; 114(3):557-65. PubMed ID: 11552980
[TBL] [Abstract][Full Text] [Related]
25. The staurosporine analog, Ro-31-8220, induces apoptosis independently of its ability to inhibit protein kinase C.
Han Z; Pantazis P; Lange TS; Wyche JH; Hendrickson EA
Cell Death Differ; 2000 Jun; 7(6):521-30. PubMed ID: 10822275
[TBL] [Abstract][Full Text] [Related]
26. Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells.
Budworth J; Davies R; Malkhandi J; Gant TW; Ferry DR; Gescher A
Br J Cancer; 1996 May; 73(9):1063-8. PubMed ID: 8624264
[TBL] [Abstract][Full Text] [Related]
27. Bortezomib activity and in vitro interactions with anthracyclines and cytarabine in acute myeloid leukemia cells are independent of multidrug resistance mechanisms and p53 status.
Minderman H; Zhou Y; O'Loughlin KL; Baer MR
Cancer Chemother Pharmacol; 2007 Jul; 60(2):245-55. PubMed ID: 17096161
[TBL] [Abstract][Full Text] [Related]
28. Characterisation of novel human lung carcinoma cell lines selected for resistance to anti-neoplastic analogues of staurosporine.
Courage C; Bradder SM; Jones T; Schultze-Mosgau MH; Gescher A
Int J Cancer; 1997 Nov; 73(5):763-8. PubMed ID: 9398059
[TBL] [Abstract][Full Text] [Related]
29. The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistance.
Utz I; Hofer S; Regenass U; Hilbe W; Thaler J; Grunicke H; Hofmann J
Int J Cancer; 1994 Apr; 57(1):104-10. PubMed ID: 7908658
[TBL] [Abstract][Full Text] [Related]
30. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.
Grant S; Turner AJ; Freemerman AJ; Wang Z; Kramer L; Jarvis WD
Exp Cell Res; 1996 Oct; 228(1):65-75. PubMed ID: 8892972
[TBL] [Abstract][Full Text] [Related]
31. Signal transduction for proliferation of glioma cells in vitro occurs predominantly through a protein kinase C-mediated pathway.
Baltuch GH; Yong VW
Brain Res; 1996 Feb; 710(1-2):143-9. PubMed ID: 8963653
[TBL] [Abstract][Full Text] [Related]
32. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs.
Chaudhary PM; Roninson IB
J Natl Cancer Inst; 1993 Apr; 85(8):632-9. PubMed ID: 8096875
[TBL] [Abstract][Full Text] [Related]
33. Taxol-enhanced cytotoxic effect of radiation in human promyelocytic leukemia cells: relative resistance of multidrug-resistant HL-60 cells in vitro.
Sedlák J; Suliková M; Chorváth M; Hunáková L; Novotný L; Laginová V; Sevcíková L; Boljesiková E; Chorváth B
Neoplasma; 1997; 44(3):172-7. PubMed ID: 9372859
[TBL] [Abstract][Full Text] [Related]
34. Activation of protein kinase C prevents induction of apoptosis by geranylgeraniol in human leukemia HL60 cells.
Masuda Y; Yoda M; Ohizumi H; Aiuchi T; Watabe M; Nakajo S; Nakaya K
Int J Cancer; 1997 May; 71(4):691-7. PubMed ID: 9178828
[TBL] [Abstract][Full Text] [Related]
35. Intrinsic cytotoxicity and chemomodulatory actions of novel phenethylisothiocyanate sphingoid base derivatives in HL-60 human promyelocytic leukemia cells.
Johnson CR; Chun J; Bittman R; Jarvis WD
J Pharmacol Exp Ther; 2004 May; 309(2):452-61. PubMed ID: 14724218
[TBL] [Abstract][Full Text] [Related]
36. Interactions between 2-fluoroadenine 9-beta-D-arabinofuranoside and the kinase inhibitor UCN-01 in human leukemia and lymphoma cells.
Harvey S; Decker R; Dai Y; Schaefer G; Tang L; Kramer L; Dent P; Grant S
Clin Cancer Res; 2001 Feb; 7(2):320-30. PubMed ID: 11234887
[TBL] [Abstract][Full Text] [Related]
37. Modulation of apoptosis in rat thymocytes by analogs of staurosporine: lack of direct association with inhibition of protein kinase C.
Harkin ST; Cohen GM; Gescher A
Mol Pharmacol; 1998 Oct; 54(4):663-70. PubMed ID: 9765509
[TBL] [Abstract][Full Text] [Related]
38. 12-O-tetradecanoyl phorbol 13-acetate, protein kinase C (PKC) activator, protects human leukemia HL-60 cells from taxol-induced apoptosis: possible role for extracellular signal-regulated kinase.
Pae HO; Yoo JC; Choi BM; Lee EJ; Song YS; Chung HT
Immunopharmacol Immunotoxicol; 2000 Feb; 22(1):61-73. PubMed ID: 10737257
[TBL] [Abstract][Full Text] [Related]
39. Analysis of mechanisms contributing to AraC-mediated chemoresistance and re-establishment of drug sensitivity by the novel heterodinucleoside phosphate 5-FdUrd-araC.
Maier S; Strasser S; Saiko P; Leisser C; Sasgary S; Grusch M; Madlener S; Bader Y; Hartmann J; Schott H; Mader RM; Szekeres T; Fritzer-Szekeres M; Krupitza G
Apoptosis; 2006 Mar; 11(3):427-40. PubMed ID: 16538382
[TBL] [Abstract][Full Text] [Related]
40. Isothiocyanates induce cell cycle arrest, apoptosis and mitochondrial potential depolarization in HL-60 and multidrug-resistant cell lines.
Jakubikova J; Bao Y; Sedlak J
Anticancer Res; 2005; 25(5):3375-86. PubMed ID: 16101152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
